Centessa Pharmaceuticals (NASDAQ:CNTA) Earns Buy Rating from Guggenheim
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Guggenheim in a research report issued on Monday,Benzinga reports. Separately, TD Cowen initiated coverage on Centessa Pharmaceuticals in a research note on Tuesday, January 7th. They set a “buy” rating for the company. Seven investment analysts have rated […]
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Guggenheim in a research report issued on Monday,Benzinga reports. Separately, TD Cowen initiated coverage on Centessa Pharmaceuticals in a research note on Tuesday, January 7th. They set a “buy” rating for the company. Seven investment analysts have rated […]
